As increased TNFα production is a hallmark of IBD and a common characteristic with LPS induced inflammatory reaction, first we examined the potential effect of T cell-specific PARP2 downregulation on the intestinal tissue concentration of this cytokine with or without LPS treatment. The gene discussed is PARP2; the disease is inflammatory bowel disease.